Showing posts with label Software. Show all posts
Showing posts with label Software. Show all posts

Monday, July 20, 2020

Report explores the Healthcare EDI Market worth $3.77 Billion by 2022


The rising adoption of EDI services by hospitals in supply chain management and government efforts to improve healthcare coverage & streamline healthcare delivery & reimbursement processes are majorly contributing to the growth of the European healthcare EDI market, which holds the second-largest market share

The Healthcare EDI Market is expected to reach USD 3.77 Billion by 2022 from an estimated USD 2.56 Billion in 2017, at a CAGR of 8.1%. The growth of the market is mainly driven by the rising need to curtail healthcare costs, mandatory regulations for transaction processes, and government support for HCIT.
On the basis of component, the services segment accounted for the largest share of the global healthcare EDI market. This is primarily attributed to the increasing complexity and scale of EDI solutions, as they require extensive training programs, and rise in outsourcing activities. The services segment is also expected to grow at the highest CAGR during the forecast period.
Based on delivery mode, the web & cloud-based EDI segment accounted for the largest share of this market. The low cost of web and cloud-based EDI, non-requirement of software installations, compatibility with mobile devices, and high scalability are the major factors driving the use of web & cloud-based EDI, which has boosted the demand for effective EDI implementation.
North America accounted for the largest share of the healthcare EDI market in 2016, followed by Europe and Asia-Pacific..
The prominent players in the global healthcare EDI market are McKesson Corporation (U.S.), GE Healthcare (U.S.), Allscripts Healthcare Solutions Inc. (U.S.), Cognizant Technology Corporation (U.S.), SSI Group, LLC (U.S.), Cerner Corporation (U.S.), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (U.S.), Dell Technologies Inc. (U.S.), Quality Systems Inc. (U.S.), and Synnex Corporation (U.S.).

Friday, June 12, 2020

New report examines the Infusion Pump Software Market worth $1,044 million by 2024

Growth in the infusion pump software market is mainly driven by factors such as the increasing incidence of chronic diseases, along with rapid growth in the geriatric population, growing number of surgical procedures performed, rising demand for ambulatory and home care infusion pumps, and technological developments.
The global Infusion Pump Software Market is expected to reach USD 1,044 million by 2024 from USD 742 million in 2019, at a CAGR of 7.1%. 
On the basis of type, the infusion pump software market is segmented into Dose error reduction software (DERS), clinical workflow software, interoperability software and other software. The DERS segment held the largest share of the infusion pump software market in 2018 and this segment is also projected to register the highest growth during the forecast period. Increasing number of medication errors using infusion pumps is a major factor driving market growth. The various automated safety features offered by this software also supporting the adoption of DERS in infusion pumps.
On the basis of indication, the market is segmented into general infusion, pain & anesthesia management, insulin infusion, chemotherapy, enteral infusion, and others. The general infusion segment commanded the largest share of the market in 2018. However, the insulin infusion market is projected to register the highest CAGR owing to a significant increase in the prevalence of diabetes worldwide and the pump’s ease of use for prolonged insulin infusion.
Geographically, North America is expected to dominate the global infusion pump software market in 2018, while the Asia Pacific region is expected to register the highest CAGR during the forecast period. 
The major players operating in the infusion pump software market include BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), and Terumo Medical (Japan). Other players involved in this market include Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).

Thursday, June 11, 2020

Clinical Workflow Solutions Market : An Outlook to the Future Global Opportunities

The major factors driving the growth of this market are the rising need to curtail healthcare costs and the increasing patient volume due to the rising prevalence of chronic diseases. In addition, the government initiatives for HCIT adoption and the advantages of clinical workflow solutions in enhancing patient care and safety are also boosting the market growth.
The Clinical Workflow Solutions Market is expected to reach USD 12.1 billion by 2023 from an estimated USD 6.8 billion in 2018, at a CAGR of 12.4%.
Based on products, the clinical workflow solutions market is segmented into workflow automation solutions, care collaboration solutions, real-time communication solutions, data integration solutions, and enterprise reporting and analytics solutions. The data integration segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the growing requirement for a proper management and storage solution that can manage the increasing volume of medical records. Also the government incentives, penalties, and the necessity to cut costs are contributing towards the market growth. The data integration segment is further subsegmented into EMR integration solutions and Medical image integration solutions.
Based on end users, the clinical workflow solutions market is segmented into hospitals, long-term care facilities, and ambulatory care facilities. The hospital segment is estimated to account for the largest market share in 2018. This is because increasing number of initiatives to improve the quality of care delivered to patients and the growing need to improve profitability of healthcare operations and curtail healthcare costs. 
North America is expected to account for the largest share of the clinical workflow solutions market in 2018, followed by Europe. The dominance of the North American region can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of major market players in the region. 
The prominent players in the clinical workflow solutions market are are Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), and McKesson Corporation (US).

Wednesday, June 10, 2020

Healthcare CRM Market worth $17.4 billion by 2023 explored in latest research

Factors such as the improving quality of healthcare, improvements in healthcare systems, the growing medical tourism market in Asian countries, and increasing government initiatives are the key factors driving the growth of this market.The benefits of CRM software and a growing focus on patient engagement are the major factors driving the growth of the healthcare CRM market.
The report Healthcare CRM Market is projected to reach USD 17.4 billion by 2023 from USD 8.8 billion in 2018, at a CAGR of 14.6% during the forecast period.
Download PDF Brochure :- 
Based on end user, the healthcare CRM market is segmented into healthcare providers, the life sciences industry, and healthcare payers. The healthcare providers segment is estimated to account for the largest share of the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Healthcare providers need to interact with multiple stakeholders, including patients, physicians, other referral healthcare organizations, healthcare payer organizations, pharmaceutical companies, and consumers/potential patients, and each requires unique CRM strategies and solutions. 
On the basis of component, the healthcare CRM market is segmented into software and services. The services segment is expected to dominate the healthcare CRM market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Services form a large component of the healthcare CRM market primarily due to the indispensable role of service providers when it comes to the use of CRM solutions for healthcare. 
Geographically, the global healthcare CRM market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to hold the largest share of the healthcare CRM market. 
The key players in the healthcare CRM market are Salesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US).

Tuesday, May 26, 2020

Research details developments in the Healthcare EDI Market

The rising adoption of EDI services by hospitals in supply chain management and government efforts to improve healthcare coverage & streamline healthcare delivery & reimbursement processes are majorly contributing to the growth of the European healthcare EDI market, which holds the second-largest market share.
The Healthcare EDI Market is expected to reach USD 3.77 Billion by 2022 from an estimated USD 2.56 Billion in 2017, at a CAGR of 8.1%. The growth of the market is mainly driven by the rising need to curtail healthcare costs, mandatory regulations for transaction processes, and government support for HCIT.
Download PDF Brochure :- 
On the basis of component, the services segment accounted for the largest share of the global healthcare EDI market. This is primarily attributed to the increasing complexity and scale of EDI solutions, as they require extensive training programs, and rise in outsourcing activities. The services segment is also expected to grow at the highest CAGR during the forecast period.
Based on delivery mode, the web & cloud-based EDI segment accounted for the largest share of this market. The low cost of web and cloud-based EDI, non-requirement of software installations, compatibility with mobile devices, and high scalability are the major factors driving the use of web & cloud-based EDI, which has boosted the demand for effective EDI implementation.
North America accounted for the largest share of the healthcare EDI market in 2016, followed by Europe and Asia-Pacific. 
The prominent players in the global healthcare EDI market are McKesson Corporation (U.S.), GE Healthcare (U.S.), Allscripts Healthcare Solutions Inc. (U.S.), Cognizant Technology Corporation (U.S.), SSI Group, LLC (U.S.), Cerner Corporation (U.S.), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (U.S.), Dell Technologies Inc. (U.S.), Quality Systems Inc. (U.S.), and Synnex Corporation (U.S.).

Tuesday, May 19, 2020

Patient Registry Software Market Set for Rapid Growth and Trend by 2022

The growth of the market is attributed to the growing implementation of government initiatives to build patient registries, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and growing use of patient registry data for post-marketing surveillance. The rising number of accountable care organizations, emergence of cloud-based patient registry solutions & high adoption rate of subscription models, and shifting focus towards patient-powered research networks (PPRNS) are expected to offer significant growth opportunities for players in the coming years.
The global Patient Registry Software Market is expected to reach USD 1,429.1 Million by 2022 from USD 807.4 Million in 2017, at a CAGR of 12.1%.
Based on type of registry, the market is segmented into product registries (medical device and drug registries), health service registries, and disease registries (diabetes registries, cardiovascular registries, cancer registries, rare disease registries, asthma registries, chronic kidney disease registries, orthopedic registries, and other registries). The disease registries segment is expected to dominate the market in 2017. The growth of this segment can be attributed to the factors such as increasing aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and increasing adoption of EHRs across the globe.
Based on end user, the market is segmented into government organizations & TPAs (third-party administrators); hospitals and medical practices; private payers; pharmaceutical, biotechnology, and medical device companies; and research centers. The hospitals and medical practices segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors like increasing focus on improving the quality of patient care, growing adoption of EHRs, and implementation of pay-for-performance initiatives.
In 2017, North America is expected to account for the largest share of the market. Growth in the North American market can largely be attributed to the presence of major patient registry software developing players and the high adoption rate of these solutions in the region. Other drivers include the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on population health management & health information exchange, increasing adoption of HCIT as a cost-containment measure, and increasing participation of non-profit and private organizations in improving patient care quality.
The patient registry software market is fragmented with several big and small players. Players offer several products across different subsegments of this market. Key players in this market include Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison Technologies. (US), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc. Company) (US), Dacima Software Inc. (US), Global Vision Technologies, Inc. (US), ifa systems AG, (Germany), INC RESEARCH HOLDINGS, INC. (US), M2S (A Medstreaming Company) (US), Optum, Inc (A part of UnitedHealth Group Incorporated) (US), EVADO Pty. Ltd. (Australia), and Velos, Inc. (US).

Thursday, April 16, 2020

Healthcare CRM Market by Component, Functionality, Delivery & End user 2023

The research report "Healthcare CRM Market by Component (Software, Service), Delivery (On premise, Cloud, Public, Private, Hybrid), End user (Hospital, ASC, Payers, Life Science), Functionality (CSS, Marketing, Sales, Digital Marketing, AI, Analytics) - Global Forecast to 2023", published by MarketsandMarkets™, the Healthcare CRM Market is projected to reach USD 17.4 billion by 2023 from USD 8.8 billion in 2018, at a CAGR of 14.6% during the forecast period.

Further more information in details about Healthcare CRM Market Best Chance to increase growth in revenue of your company.


Healthcare providers are expected to dominate the healthcare CRM end-user market in 2018 
Based on end user, the Healthcare CRM Market is segmented into healthcare providers, the life sciences industry, and healthcare payers. The healthcare providers segment is estimated to account for the largest share of the Healthcare CRM Market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Healthcare providers need to interact with multiple stakeholders, including patients, physicians, other referral healthcare organizations, healthcare payer organizations, pharmaceutical companies, and consumers/potential patients, and each requires unique CRM strategies and solutions. Moreover, there is a growing focus on patient engagement, which is again likely to drive the market for this segment.
Browse in-depth TOC on “Healthcare CRM Market”
62 – Tables  
34 – Figures  
121 – Pages  
Healthcare CRM services to grow at the highest CAGR during 2018-2023 
On the basis of component, the Healthcare CRM Market is segmented into software and services. The services segment is expected to dominate the Healthcare CRM Market in 2018. This segment is also expected to register the highest CAGR during the forecast period. Services form a large component of the Healthcare CRM Market primarily due to the indispensable role of service providers when it comes to the use of CRM solutions for healthcare. In terms of IT usage and skills, the healthcare industry is still in the nascent stage; it relies heavily on service providers for CRM-related services and support services, such as implementation, integration, training and education, maintenance, and technology upgrades. The recurring need for services such as software upgrades and maintenance is the key factor supporting the growth of this segment.
North America to dominate the market, followed by Europe 
Geographically, the global Healthcare CRM Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to hold the largest share of the Healthcare CRM Market. Some of the major factors driving the growth of this market include government initiatives and regulations to encourage the adoption of healthcare IT, growing pressure on healthcare organizations to focus on patient engagement for patient retention, growing EHR adoption, growing focus of CRM providers on developing and commercializing AI and analytics-powered advanced CRM solutions, and the increasing number of ACOs. However, the market in Asia is estimated to grow at the highest CAGR during the forecast period. Factors such as the improving quality of healthcare, improvements in healthcare systems, the growing medical tourism market in Asian countries, and increasing government initiatives are the key factors driving the growth of this market.
The key players in the Healthcare CRM Market are Salesforce.com, Inc. (US), SAP SE (Germany), Oracle (US), Microsoft (US), IBM (US), Influence Health (US), SugarCRM (US), Accenture (Ireland), Healthgrades (US), and Infor, Inc. (US).

x

Antibody Therapeutics Market : Driven by Advances in Biologics and Expanding Clinical Applications

The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5...